(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Brand names, (3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Analogs
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Brand Names Mixture
- No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Chemical_Formula
C14H10N2O2
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One RX_link
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One fda sheet
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One msds (material safety sheet)
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Synthesis Reference
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Molecular Weight
238.245 g/mol
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Melting Point
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One H2O Solubility
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One State
Solid
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One LogP
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Dosage Forms
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Indication
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Pharmacology
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Absorption
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One side effects and Toxicity
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Patient Information
No information avaliable
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One Organisms Affected
No information avaliable
